Filgotinib Shows Potential in Rheumatoid ArthritisFilgotinib Shows Potential in Rheumatoid Arthritis

Response to the Janus kinase 1 inhibitor was good in patients with rheumatoid arthritis who have highly active disease despite methotrexate therapy, new research showed. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news